Close Menu
Home › Becton Dickinson Triplex STD Test Clears FDA Review

Becton Dickinson Triplex STD Test Clears FDA Review

Sep 14, 2016

NEW YORK (GenomeWeb) – A triplex test from Becton Dickinson to detect chlyamydia, gonorrhea, and trichomonas has been cleared by the US Food and Drug Administration, the company announced today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Molecular Diagnostics

  1. Exact Sciences Sues Johns Hopkins University for 'Improperly' Demanding Royalties

  2. FDA Clears NantHealth Tumor-Normal Whole-Exome Test

  3. Invitae to Acquire Genetic Counseling Chatbot Developer for $50M

  4. Natera Outlines Plans for Cancer, Transplant Assays; Provides Update on Legal Proceedings

    Premium

  5. T2 Biosystems Q3 Revenues Drop 36 Percent; Firm Suffers Ransom Cyberattack

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.